ABSTRACT
INTRODUCTION: Cytomegalovirus (CMV) is a major cause of childhood disabilities, and consensus recommendations emphasize the importance of hygienic measures to reduce perinatal infection. Our study aimed to evaluate the level of awareness about CMV among health professionals and pregnant women. METHODS: We submitted a 20-item online survey regarding CMV perinatal infection to all obstetricians and midwives in Catalonia (Spain) and a 7-item lay version of the questionnaire to 700 pregnant women. Levels of knowledge were compared among groups. RESULTS: Of the 1,449 health professionals approached, 338 surveys were answered. 72% of professionals considered CMV a relevant problem. 47% of obstetricians and 28% of midwives (p ≤ 0.001) routinely informed pregnant women, and less than half knew the risk of fetal transmission. We observed significant differences in knowledge between obstetricians and midwives concerning the risks of recurrent infections, risk of transmission, and risk of severe infection (60.7% vs. 45.6%, p = 0.006 and 50.6% vs. 22.5%, p ≤ 0.001); and regarding maternal and neonatal symptoms and newborn sequelae (23% vs. 8.8%, p ≤ 0.001). Of the 700 women approached, we obtained a response rate of 72%. Only 23% had previously heard about CMV, 22% identified transmission routes, and 15% preventive measures. Compared to women without risk factors for CMV infection, women at greater risk had heard more about CMV (mothers of children <3 years: 36% vs. 20%, p < 0.001; occupational exposure: 43% vs. 20%, p ≤ 0.001) and had received more information (mothers of children <3 years: 18% vs. 9.5%, p ≤ 0.001; occupational exposure: 23% vs. 9.3%, p = 0.001). CONCLUSION: Health care professionals have limited knowledge about CMV and may fail to enforce preventive measures. While pregnant women have limited awareness about CMV infection, they recognize the need for information. Health campaigns should be promoted to enhance awareness about this perinatal infection.
Subject(s)
Cytomegalovirus Infections , Pregnancy Complications, Infectious , Child , Cytomegalovirus , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/prevention & control , Female , Health Knowledge, Attitudes, Practice , Health Personnel , Humans , Infant, Newborn , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/prevention & control , Pregnant WomenABSTRACT
OBJECTIVE: To assess the added value of maternal serum levels of IL-6 in women with preterm-prelabor rupture of membranes (PPROM) as a non-invasive test for the prediction of histological chorioamnionitis (HCA). METHODS: This was a prospective cohort study of pregnant women between 20 + 0 and 36 + 6 weeks of gestation with a confirmed diagnosis of PPROM. Logistic regression models were created for the prediction of HCA and compared by assessing the improvement in their Naegelkerke R2 as a measure of goodness of fit. Predictive performance of all models was assessed by receiver operating characteristics curve (ROC) analysis and compared by the DeLong method. RESULTS: From 47 women with PPROM, 31 (66%) developed HCA. Maternal serum IL-6 ≥19.5 pg/dL was the best cut-off point for the prediction of HCA (OR = 15; 95% CI: 3.6-61; p < 0.01). A model comprising maternal characteristics and IL-6 ≥19.5 pg/dL showed an area under the curve of 0.85 (95% CI: 0.74-0.95), significantly improving the previous models of IL-6 ≥19.5 pg/dL (R2: 23.3 vs. 34.1%; p = 0.01) or maternal characteristics (R2: 8.4 vs. 34.1%; p < 0.01). CONCLUSIONS: A model comprising maternal serum levels of IL-6 plus maternal characteristics proves to be a good non-invasive predictor of HCA.
Subject(s)
Chorioamnionitis/diagnosis , Fetal Membranes, Premature Rupture/diagnosis , Interleukin-6/blood , Adult , Biomarkers/blood , Chorioamnionitis/blood , Female , Fetal Membranes, Premature Rupture/blood , Gestational Age , Humans , Infant, Newborn , Pregnancy , Prospective Studies , Young AdultABSTRACT
Background and objectives: In recent years, a growing body of research has focused on identifying possible biological markers for suicidal behavior, including infective and immunological markers. In this paper, our aim was to review available evidence concerning the association between cytomegalovirus (CMV) infection and suicide. Materials and Methods: A systematic search according to the PRISMA statement was performed on Pubmed. After the screening procedure, we identified five relevant papers. Results: We found inconsistent evidence linking CMV infection and suicide, with some papers reporting an association between CMV seropositivity and suicidal behavior, and others not finding the association. Conclusions: With the evidence available presently, it is not possible to infer whether there is a correlation between suicide and CMV infection.
Subject(s)
Cytokines/metabolism , Cytomegalovirus Infections/immunology , Cytomegalovirus/immunology , Intracellular Signaling Peptides and Proteins/immunology , Suicide, Attempted/psychology , Biomarkers/metabolism , Cytomegalovirus Infections/complications , Cytomegalovirus Infections/psychology , Humans , Predictive Value of Tests , Risk Factors , Suicidal IdeationABSTRACT
OBJECTIVE: To describe the development of an artificial placenta (AP) system in sheep with learning curve and main bottlenecks to allow survival up to one week. METHODS: A total of 28 fetal sheep were transferred to an AP system at 110-115 days of gestation. The survival goal in the AP system was increased progressively in three consecutive study groups: 1-3 h (n = 8), 4-24 h (n = 10) and 48-168 h (n = 10). Duration of cannulation procedure, technical complications, pH, lactate, extracorporeal circulation (EC) circuit flows, fetal heart rate, and outcomes across experiments were compared. RESULTS: There was a progressive reduction in cannulation complications (75%, 50% and 0%, p = 0.004), improvement in initial pH (7.20 ± 0.06, 7.31 ± 0.04 and 7.33 ± 0.02, p = 0.161), and increment in the rate of experiments reaching survival goal (25%, 70% and 80%, p = 0.045). In the first two groups, cannulation accidents, air bubbles in the extracorporeal circuit, and thrombotic complications were the most common cause of AP system failure. CONCLUSIONS: Achieving a reproducible experimental setting for an AP system is extremely challenging, time- and effort-consuming, and requires a highly multidisciplinary team. As a result of the learning curve, we achieved reproducible transition and survival up to 7 days. Extended survival requires improving instrumentation with custom-designed devices.
ABSTRACT
BACKGROUND/OBJECTIVE: Currently, there is no validated treatment for fetal cytomegalovirus (CMV). Two studies suggest that high-dose maternal valacyclovir decreases fetal viral load and improves outcomes in moderately-symptomatic fetuses. We offered valacyclovir in cases of fetal infection lacking ultrasound abnormalities or with non-severe infection. Maternal tolerability, fetal outcome and newborn blood viral load were evaluated in pregnancies of mothers receiving valacyclovir. STUDY DESIGN: We performed a case series including 8 pregnancies with fetal CMV classified as unaffected/mildly-moderately affected. Mothers received valacyclovir (8 g/24h) from fetal infection diagnosis to delivery. Standard newborn evaluation was performed, and viremia was determined in the first 48 h of life and compared according to length of maternal treatment and presence/absence of prenatal anomalies. RESULTS: Valacyclovir was administered at a median gestational age of 26.5 weeks (23.8-33.1) in 3 cases without fetal abnormalities, and 5 with mild/moderate abnormalities. Three were 3 first trimester primary infections, one non-primary infection, and in 4 the type of infection was unknown. Valacyclovir was well-tolerated. Fetal features did not progress. Three newborns were asymptomatic, and one was severely affected (bilateral chorioretinitis). The median newborn viral load (IQR) was 502 IU/mL (231-191781) with lower levels when maternal treatment was administered ≥10 weeks, and in cases without fetal abnormalities [median 234 IU/mL (228-711) vs. 4061 (292-510500) p = .18; and 234 IU/mL (228-379500) vs. 711 IU/mL (292-4061) p = .65, respectively], these differences being non-significant. CONCLUSIONS: Fetal CMV lesions remained stable with high-dose maternal valacyclovir. Newborn viral load was unchanged despite treatment duration and fetal/neonatal abnormalities. SUMMARY: Fetal cytomegalovirus lesions remained stable with high-dose maternal valacyclovir. Newborn viral load was unchanged despite treatment duration and fetal/newborn abnormalities.
Subject(s)
Cytomegalovirus Infections , Fetal Diseases , Pregnancy Complications, Infectious , Cytomegalovirus , Cytomegalovirus Infections/diagnosis , Female , Fetal Diseases/diagnosis , Humans , Infant , Infant, Newborn , Infectious Disease Transmission, Vertical , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Valacyclovir/therapeutic use , Viral LoadABSTRACT
Objective: To assess fetal liver volume (FLV) by magnetic resonance imaging (MRI) in cytomegalovirus (CMV)-infected fetuses compared to a group of healthy fetuses. Method: Most infected cases were diagnosed by the evidence of ultrasound abnormalities during routine scans and in some after maternal CMV screening. CMV-infected fetuses were considered severely or mildly affected according to prenatal brain lesions identified by ultrasound (US)/MRI. We assessed FLV, the FLV to abdominal circumference (AC) ratio (FLV/AC-ratio), and the FLV to fetal body volume (FBV) ratio (FLV/FBV-ratio). As controls, we included 33 healthy fetuses. Hepatomegaly was evaluated post-mortem in 11 cases of congenital CMV infection. Parametric trend and intraclass correlation analyses were performed. Results: There were no significant differences in FLV between infected (n = 32) and healthy fetuses. On correcting the FLV for AC and FBV, we observed a significantly higher FLV in CMV-infected fetuses. There were no significant differences in the FLV, or the FLV/AC or FLV/FBV-ratios according to the severity of brain abnormalities. There was excellent concordance between the fetal liver weight estimated by MRI and liver weight obtained post-mortem. Hepatomegaly was not detected in any CMV-infected fetus. Conclusion: In CMV-infected fetuses, FLV corrected for AC and FBV was higher compared to healthy controls, indicating relative hepatomegaly. These parameters could potentially be used as surrogate markers of liver enlargement.
ABSTRACT
The objective of this study was to evaluate the performance of quantitative ultrasound of fetal lung texture analysis in predicting neonatal respiratory morbidity (NRM) in twin pregnancies. This was an ambispective study involving consecutive cases. Eligible cases included twin pregnancies between 27.0 and 38.6 weeks of gestation, for which an ultrasound image of the fetal thorax was obtained within 48 h of delivery. Images were analyzed using quantusFLM® version 3.0. The primary outcome of this study was neonatal respiratory morbidity, defined as the occurrence of either transient tachypnea of the newborn or respiratory distress syndrome. The performance of quantusFLM® in predicting NRM was analyzed by matching quantitative ultrasound analysis and clinical outcomes. This study included 166 images. Neonatal respiratory morbidity occurred in 12.7% of cases, and it was predicted by quantusFLM® analysis with an overall sensitivity of 42.9%, specificity of 95.9%, positive predictive value of 60%, and negative predictive value of 92.1%. The accuracy was 89.2%, with a positive likelihood ratio of 10.4, and a negative likelihood ratio of 0.6. The results of this study demonstrate the good prediction capability of NRM in twin pregnancies using a non-invasive lung texture analysis software. The test showed an overall good performance with high specificity, negative predictive value, and accuracy.
ABSTRACT
To evaluate the concordance of the risk of neonatal respiratory morbidity (NRM) assessed by quantitative ultrasound lung texture analysis (QuantusFLM) between twin fetuses of the same pregnancy. Prospective study conducted in twin pregnancies. Fetal ultrasound lung images were obtained at 26.0-38.6 weeks of gestation. Categorical (high or low) and continuous results of the risk of NRM were compared between twins. Fetal ultrasound lung images from 131 pairs (262 images) of twins were included. The images were classified into three gestational age ranges: Group 1 (26.0-29.6 weeks, 78 images, 39 pairs [29.8%]); Group 2 (30.0-33.6 weeks, 98 images, 49 pairs [37.4%]) and Group 3 (34.0-38.6 weeks, 86 images, 43 pairs [32.8%]). Concordance was good in Groups 1 and 3 and moderate in Group 2. In Groups 2 and 3 at least one fetus presented high-risk results in 26.5% and 11.6% of twin pairs, respectively. Only gestational age < 32 weeks, gestational diabetes mellitus, and spontaneous conception were associated with a high risk of NRM in Group 2. There was good concordance of the risk of NRM between twins < 30.0 weeks and > 34.0 weeks. From 30.0 to 33.6 weeks 26.5% of the twin pairs had discordant results, with moderate concordance of the risk of NRM.
Subject(s)
Lung , Pregnancy, Twin , Disease Progression , Female , Fetus/diagnostic imaging , Humans , Infant , Infant, Newborn , Lung/diagnostic imaging , Morbidity , Pregnancy , Prospective StudiesABSTRACT
Pregnant women may be at higher risk of severe complications associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which may lead to obstetrical complications. We performed a case control study comparing pregnant women with severe coronavirus disease 19 (cases) to pregnant women with a milder form (controls) enrolled in the COVI-Preg international registry cohort between March 24 and July 26, 2020. Risk factors for severity, obstetrical and immediate neonatal outcomes were assessed. A total of 926 pregnant women with a positive test for SARS-CoV-2 were included, among which 92 (9.9%) presented with severe COVID-19 disease. Risk factors for severe maternal outcomes were pulmonary comorbidities [aOR 4.3, 95% CI 1.9-9.5], hypertensive disorders [aOR 2.7, 95% CI 1.0-7.0] and diabetes [aOR2.2, 95% CI 1.1-4.5]. Pregnant women with severe maternal outcomes were at higher risk of caesarean section [70.7% (n = 53/75)], preterm delivery [62.7% (n = 32/51)] and newborns requiring admission to the neonatal intensive care unit [41.3% (n = 31/75)]. In this study, several risk factors for developing severe complications of SARS-CoV-2 infection among pregnant women were identified including pulmonary comorbidities, hypertensive disorders and diabetes. Obstetrical and neonatal outcomes appear to be influenced by the severity of maternal disease.
Subject(s)
COVID-19/virology , Pregnancy Complications, Infectious/virology , Pregnant Women , SARS-CoV-2/pathogenicity , Adult , Case-Control Studies , Female , Humans , Pregnancy , Pregnancy Outcome , Premature Birth/virology , Risk FactorsABSTRACT
BACKGROUND AND OBJECTIVE: Cytomegalovirus (CMV) remains a major cause of congenital infection and disease. During pregnancy, symptomatic cases can be detected through ultrasound (US) features, nevertheless, prognostic assessment is difficult. The aim of this study was to assess the predictive value of specific blood parameters in CMV infected fetuses. STUDY DESIGN: Twenty-eight CMV-infected fetuses in which a cordocentesis had been performed were included. Fetuses were considered severely or mildly affected according to prenatal US/MRI brain damage. Fetal blood parameters were assessed for the prediction of severe brain abnormalities, and compared according to the trimester of pregnancy. Logistic regression and receiver operating curve analysis were performed. RESULTS: Thrombocytopenia (≤100,000/mm3; p:0.03) and high levels of gamma-glutamyl transpeptidase (GGT) (≥151 IU/L; p:0.02) signaled severity. For the prediction of brain damage, GGT levels ≥ 183 UI/l achieved 71% sensitivity, 83% specificity (AUC: 0.78), and OR of 2.05 (95% CI: 1.22-3.43) per 100 IU/l increase, adjusted for gestational age. However, thrombocytopenia (91% vs 50%; p: 0.04), ß2 microglobulin >10.4â¯mg/l (60% vs 0% p: 0.03), CMV-DNA >50,000 copies/ml (80% vs 25%; p: 0.02), and positive IgM (70% vs 17%; p: 0.04) were observed significantly more often in severely damaged fetuses sampled ≤28 weeks than thereafter. CONCLUSION: In CMV infected fetuses, thrombocytopenia and high levels of GGT are associated with severe US/MRI brain abnormalities. Nevertheless, among severely affected fetuses, blood parameters, with exception of GGT, change according to gestational age. Fetal blood could be less predictive of brain damage in the third trimester.
Subject(s)
Brain/abnormalities , Cytomegalovirus Infections/diagnosis , Cytomegalovirus/isolation & purification , Fetal Diseases/diagnosis , Pregnancy Complications, Infectious/diagnosis , Cordocentesis , Cytomegalovirus Infections/blood , DNA, Viral/blood , Female , Fetal Blood/chemistry , Fetal Blood/cytology , Fetal Diseases/blood , Gestational Age , Humans , Pregnancy , Pregnancy Complications, Infectious/blood , Prognosis , Sensitivity and SpecificityABSTRACT
Se trata de paciente femenina, G1 de 21 años referida por sospecha de cardiopatía congénita (aurícula única). Durante la entrevista, no reporta antecedentes médicos relevantes. Se realiza ultrasonido fetal, revelando los siguientes hallazgos ultrasonográficos: Válvula tricúspide displásica, elongada, engrosada e hiperecogénica Desplazamiento apical de la valva septal de la válvula tricúspide. Ventrículo derecho con tamaño reducido Incremento en el septum inter-ventricular Atrio derecho incrementado de tamaño Efusión pericárdica Regurgitación (insuficiencia) tricúspidea significativa El chorro de la regurgitación de origen apical (provisto por Infomedic International)
The patient is a 21-year-old female patient, G1, referred for suspected congenital heart disease (single atrium). During the interview, she reported no relevant medical history. Fetal ultrasound was performed, revealing the following ultrasonographic findings: - Dysplastic, elongated, thickened and hyperechogenic tricuspid valve.- Apical displacement of the septal leaflet of the tricuspid valve. - Right ventricle with reduced size- Increased interventricular septum.- Cardiomegaly. - Increased right atrium size- Pericardial effusion- Significant tricuspid regurgitation (insufficiency).- Regurgitation jet of apical origin (provided by Infomedic International)
ABSTRACT
La toxoplasmosis es una infección provocada por el parásito unicelular Toxoplasma gondii. Según las encuestas serológicas de la Tercera Encuesta Nacional de Salud y Nutrición en los Estados Unidos, alrededor del 23% de los adolescentes y adultos tienen signos serológicos de infección por T. gondii, de los cuales el 15% son mujeres en edad fértil. Estas infecciones suelen ser asintomáticas o causar síntomas leves en el adulto (como fiebre, malestar general y linfadenopatía), pero la infección en la mujer embarazada puede provocar graves problemas de salud en el feto si se transmite el parásito (toxoplasmosis congénita) y ocasionar secuelas graves en el bebé como coriorretinits, retraso mental, ceguera, sordera sensorineural y epilepsia. No hay evidencia concluyente de que la prueba y el cuidado preconcepcional reduzcan la infección por Toxoplasma gondii o mejoren el tratamiento de las mujeres infectadas. Por otro lado, si se realiza el asesoramiento preconcepcional, las mujeres que dieron positivo pueden estar tranquilas de que no corren riesgo de infección durante el embarazo y las que dieron negativo pueden recibir consejos sobre cómo prevenir la infección. Las mujeres que se infectan durante el embarazo deben recibir tratamiento. Se deben implementar programas educativos y de detección temprana para las embarazadas que sean rentables para reducir el impacto financiero y emocional de esta enfermedad. (provisto por Infomedic International)
Toxoplasmosis is an infection caused by the single-celled parasite Toxoplasma gondii. According to serologic surveys from the Third National Health and Nutrition Survey in the United States, about 23% of adolescents and adults have serologic signs of T. gondii infection, of which 15% are women of childbearing age. These infections are usually asymptomatic or cause mild symptoms in the adult (such as fever, malaise, and lymphadenopathy), but infection in the pregnant woman can cause serious health problems in the fetus if the parasite is transmitted (congenital toxoplasmosis) and cause severe sequelae in the infant such as chorioretinits, mental retardation, blindness, sensorineural deafness, and epilepsy. There is no conclusive evidence that preconception testing and care reduces Toxoplasma gondii infection or improves treatment of infected women. On the other hand, if preconception counseling is performed, women who tested positive can be reassured that they are not at risk of infection during pregnancy and those who tested negative can receive advice on how to prevent infection. Women who become infected during pregnancy should be treated. Cost-effective educational and early detection programs for pregnant women should be implemented to reduce the financial and emotional impact of this disease. (provided by Infomedic International)